Company Filing History:
Years Active: 2014
Title: Martin Gastens: Innovator in Pharmaceutical Formulations
Introduction
Martin Gastens is a notable inventor based in Wachenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations that enhance the efficacy and comfort of treatments.
Latest Patents
Gastens holds a patent for "High concentration anti-TNFα antibody liquid formulations." This invention provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFa antibody, or an antigen-binding portion thereof. The formulation is designed to reduce pain associated with injection in a subject by at least about 50% when compared to injecting an otherwise identical formulation comprising at least one salt and/or at least one buffer. Additionally, it offers increased bioavailability upon subcutaneous administration into a subject.
Career Highlights
Martin Gastens is associated with AbbVie Biotechnology Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in antibody formulations has positioned him as a key player in the development of effective therapeutic options.
Collaborations
Gastens collaborates with esteemed colleagues, including Michael Neu and Markus Tschoepe, to advance research and development in the field of biotechnology.
Conclusion
Martin Gastens exemplifies the spirit of innovation in pharmaceuticals, with his patented formulations promising to improve patient experiences and treatment outcomes. His work continues to influence the industry positively.